Share Name Share Symbol Market Type Share ISIN Share Description
Woodford Patient Capital Trust LSE:WPCT London Ordinary Share GB00BVG1CF25 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.50p +0.48% 103.90p 103.40p 104.20p 104.40p 103.20p 103.50p 592,590 16:35:09
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 1.3 -0.7 -0.1 - 859.25

Woodford Patient Capital Share Discussion Threads

Showing 1151 to 1174 of 1175 messages
Chat Pages: 47  46  45  44  43  42  41  40  39  38  37  36  Older
DateSubjectAuthorDiscuss
26/7/2017
08:48
Would the following change in listing account for recent price action? It being the case, I'm surprised it had not previously been referred to, for it appears that as of 22/06/17 WPCT was included in FTSE250 listing. Once promoted in recent FTSE changes, it's then available to wider Institutional interest and therefore may account for added market interest :- HTtps://uk.investing.com/news/economic-indicators/inmarsat-to-join-ftse-100,-replace-aggreko-52676
mazarin
21/7/2017
09:53
Here's a link to some Technical indicators (stock evaluation tools) for those who like numbers, confirming recent positive moves in price action : HTtps://finnewsweek.com/tale-of-the-ticker-woodford-patient-capital-trust-plc-wpct-l-moves-on-volume/120247/ Edit: I note that both Prothena (PRTA) and Purplebricks (PURP) today made strong gains (at +1% & +5%) respectively)
mazarin
20/7/2017
19:06
Prothena - the largest holding by some margin-has broken out of its medium term range. It's been heavily shorted; presumably now unwinding.
spin doctor
20/7/2017
11:28
Thanks, just trying to make some sense of recent price action
mazarin
20/7/2017
09:58
mazarin - how the NAV is arrived at is here, From post #1013: There are strict rules for valuing unquoted companies: Http://www.privateequityvaluation.com/download/i/mark_dl/u/4012990401/4625734325/151222%20IPEV%20Valuation%20Guidelines%20December%202015%20Final.pdf Valuation guidelines, p11. I don't see the point of spending money on a daily NAV when so much of the portfolio is unquoted. As for how the share price is determined, it's quite simply supply and demand with trades going through market makers*. I suspect there will soon be selling by frustrated holders who bought in the 2015 gold rush and want rid. If I actually knew what moved share prices, I'd be rather richer than I am. *EDIT: it's actually traded on SETS too, though not many participants it seems.
jonwig
20/7/2017
09:35
WPCT has been doing quite well since picking up in May, after several years of decline and lethargy. Unlike ordinary quoted Companies, I'm aware WPCT is essentially a 'closed' Fund that is fully subscribed and without cash in reserve, comprising of many quoted and unquoted worldwide companies, but admit I don't fully know how the 'Market' determines its intraday quoted 'sp'. I see NAV valuations issued the following day via RNS and would be grateful for insight from someone who more fully understands exactly how the value of WPCT 'sp' achieved. I'm assuming its traded by the Market through a defined number of brokers and currently appears to be in demand, hence the increased upwards momentum of late. The Market Cap of all constituent non-quoted companies is only known after their annual audits, whereas Market Cap of quoted Companies (notably PURP) due to weighting must clearly contribute to recent uplift in 'sp' values. However, I suspect current levels are possibly driven by an improvement in that indefinable quantity - 'sentiment'.
mazarin
20/7/2017
09:33
Prefer to see the share price rise supported by an eqiuvalent rise in the NAV. Danger is that this increase is froth and demand created by hype. No doubt the natural balance will reestablish itself in due course.
wtacraig1
20/7/2017
08:53
Really gaining traction now :-) Happy days chaps :-)
sawadee3
19/7/2017
16:47
There's also a 'high-water' mark IIRC so let's say it got above the 10% compounded level. It would then need to rise 10% compounded above this level not the level of 10% compounded. So say after 2 years for Woodford to earn fees it needed to be £1.21 but it got to £1.25. The following two years it would need to get to £1.25*1.1 = £1.375 and 1.25*1.1^2 = £1.5125 rather than £1.331 and £1.4641 respectively.
prewar
19/7/2017
15:44
Yes, of course even better.
chinahere
19/7/2017
14:46
Think it's compounded so for two years would need to be 1.1^2 ie £1.21 but might be wrong.
prewar
19/7/2017
14:40
It has jumped past the NAV now. Doesn't the NAV per share have to get to £1.20 now before a fee is due because it's been going for 2 years (2 * 10%)?
chinahere
19/7/2017
14:34
SP a whisker away to a premium to NAV for a long time.
a0148009
18/7/2017
13:32
Loving this today. This is my biggest holding in my pf. Bought in at 89p. Happy days to see it where it is. Am here for the long term though. Hopefully it will grow and grow.
jamesjamiebarlow
18/7/2017
12:44
Tempus in the Times has a positive piece
toffeeman
18/7/2017
12:06
Where is our terminally bewildered Liquid Kid these days? Still manically pleasuring himself in some remote field, I suppose. LOL
the air marshall
18/7/2017
12:05
Where is our terminally bewildered Liquid Kid these days? Still manically pleasuring himself in some remote field, I suppose. LOL
the air marshall
18/7/2017
11:14
Discount narrowing.
woodpecker25
18/7/2017
07:09
Citywire, yesterday: Http://citywire.co.uk/investment-trust-insider/news/woodford-trains-patient-focus-as-performance-picks-up/a1034135?ref=investment-trust-insider-latest-news-list
jonwig
17/7/2017
17:06
Whilst fully recognising that WPCT should be considered primarily as a 'longer term' investment, I think it worthy to note today's 'price action' that continues to maintain the momentum of recent weeks.
mazarin
14/7/2017
23:09
I remain confident in it too. Bio-tech performance in US will influence and just have to wait for companies in the portfolio to reach milestones. Will usually take longer than expected.
p1nkfish
14/7/2017
16:46
WPCT July update issued today: Recognises that the Fund in June returned to positive territory, due in part to upturn in biotech holdings and concludes " we remain confident in the trust’s ability to deliver attractive long-term returns to shareholders". see details: HTtps://woodfordfunds.com/words/insights/wpct-june-2017/
mazarin
13/7/2017
14:58
Let's hope. I bought at the start and sold at 113 re-bought at 95 and hope to get to set a stop loss at 107 and otherwise hold.
toffeeman
12/7/2017
09:46
Currently quoted at 99.95p having earlier momentarily touched £1.00, the big question is - will it today actually reach or exceed that by maintaining current momentum above the fund's original £1 launching price set in 2015...? It was last seen there during a declining trend recorded in April 2016. I also note that Purplebricks (next to the fund's top holding at 10.36%) continues its trend so far to make steady gains everyday this week. Will it be today? Time will tell..... ! Edit: Update WPCT actually was up, but remained just under £1, closing at 99.65p today
mazarin
Chat Pages: 47  46  45  44  43  42  41  40  39  38  37  36  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20170727 22:54:36